Results 181 to 190 of about 24,516 (282)

Safety and efficacy of eculizumab in pediatric patients with aHUS, with or without baseline dialysis [PDF]

, 2014
Bedrosian, Camille L, Greenbaum, Larry A, Kincaid, John F, Loirat, Chantal, Ogawa, Masayo, Vande Walle, Johan   +5 more
core   +1 more source

Paroxysmal nocturnal hemoglobinuria--hemolysis before and after eculizumab. [PDF]

, 2010
Hill A, Hillmen P., Kelly R, Luzzatto L, Notaro R, RISITANO, ANTONIO MARIA   +5 more
core   +1 more source

Disease-modifying treatments in paroxysmal nocturnal hemoglobinuria: a systematic review of economic evaluations. [PDF]

Cost Eff Resour Alloc
Moradi S, Khajeamiri Y, Zandi S, Keramati M, Mohammadnezhad G.   +4 more
europepmc   +1 more source

Growth in expenditure on high cost drugs in Australia [PDF]

The paper provides an overview of the expenditure of high cost drugs in Australia and examines the average annual growth of these programs. The outlook for expenditure on high cost medicines and possible policy responses is also considered.
Rebecca de Boer, Roy Harvey
core  

Reduced membrane attack complex formation in umbilical cord blood during Eculizumab treatment of the mother: a case report [PDF]

, 2019
Subagini Nagarajah, Martin Tepel, Christian Nielsen, Kristian Assing, Yaseelan Palarasah, Lise Lotte Torvin Andersen, Lotte Borg Lange, Claus Bistrup   +7 more
openalex   +1 more source

Resolution of ocular involvement with systemic eculizumab therapy in atypical hemolytic-uremic syndrome [PDF]

, 2013
R David, Sarit Hochberg-Klein, Radgonde Amer   +2 more
openalex   +1 more source

Late Onset Thrombotic Microangiopathy in Kidney Transplants; Poor Outcome Despite Eculizumab Treatment. [PDF]

Transpl Int
Glover EK, Montgomery EK, Wong EKS, Johnson S, Malina M, Marchbank KJ, Kavanagh D, Sheerin NS.   +7 more
europepmc   +1 more source

Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis. [PDF]

Transplant Cell Ther
Alhomoud M, Heller G, Cho C, Fein JA, Dahi PB, Shah GL, Politikos I, Lin R, Saldia A, Goldstein I, Jakubowski AA, Papadopoulos EB, Ponce DM, Shaffer BC, Sauter CS, Tamari R, Giralt SA, Perales MA, Scordo M.   +18 more
europepmc   +1 more source

PB1866 SUCCESSFUL MANAGEMENT OF A CHILD FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH LONG‐TERM ECULIZUMAB THERAPY

, 2019
G. Aydogan, Zafer Şalcıoğlu, Ferhan Akıcı, Ezgi Yılmaz, Tuba Nur Tahtakesen Güçer, Nazan Bayram, Nihal Özdemir   +6 more
openalex   +1 more source

Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. [PDF]

Blood Adv
Hockman A, Anuskiewicz S, Brennan E, Chowdhury SR, Coltoff A, Poston JN, Greenberg C, Djulbegovic B.   +7 more
europepmc   +1 more source